Literature DB >> 34674015

Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications.

Raul E Ruiz-Lozano1, Fabiola Velazquez-Valenzuela1, Mariana Roman-Zamudio1, Salma K Andrade-Leal1, Alejandro Rodriguez-Garcia2.   

Abstract

Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory myopathies characterized by progressive, symmetric, mainly proximal muscle weakness. DM is also characterized by cutaneous involvement. However, other clinical features, systemic involvement, histopathological findings, response to treatment, and prognosis, differ significantly. Although uncommon, ocular manifestations in DM and PM may potentially affect any structure within the eye. Notwithstanding being generally mild, ocular involvement in DM and PM may result in significant morbidity. Left untreated, significant retinal inflammation associated with hemorrhage and detachment may occur, leading to significant vision loss. This review aims to present an up-to-date overview for rheumatologists about the ocular involvement and potential complications of DM and PM and when to refer to the ophthalmologist to avoid sight-threatening complications.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anterior eye segment; Dermatomyositis; Eye manifestations; Eyelids; Polymyositis; Posterior eye segment; Retinal hemorrhage

Mesh:

Year:  2021        PMID: 34674015     DOI: 10.1007/s00296-021-05035-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  68 in total

1.  Retinitis in Dermatomyositis.

Authors:  G M Bruce
Journal:  Trans Am Ophthalmol Soc       Date:  1938

Review 2.  An overview of polymyositis and dermatomyositis.

Authors:  Andrew R Findlay; Namita A Goyal; Tahseen Mozaffar
Journal:  Muscle Nerve       Date:  2015-05       Impact factor: 3.217

3.  Ophthalmic manifestations of dermatomyositis.

Authors:  O Backhouse; B Griffiths; T Henderson; P Emery
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

4.  Inflammatory Muscle Diseases.

Authors:  Marinos C Dalakas
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

5.  Corneal Involvement of Patients with Polymyositis and Dermatomyositis.

Authors:  Zoltan Griger; Katalin Danko; Levente Bodoki; Zsuzsa Aszalos; Gabor Nemeth; Hassan Ziad; Rudolf Gesztelyi; Judit Zsuga; Peter Szodoray; Adam Kemeny-Beke
Journal:  Ocul Immunol Inflamm       Date:  2018-11-16       Impact factor: 3.070

6.  Retinopathy in a patient with thrombotic thrombocytopenic purpura complicated by polymyositis.

Authors:  T Matsuo; S Matsuura; H Nakagawa
Journal:  Jpn J Ophthalmol       Date:  2000 Mar-Apr       Impact factor: 2.447

7.  Choroidopathy with serous retinal detachment in a patient with polymyositis.

Authors:  K Hotta
Journal:  Eur J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.597

8.  Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires.

Authors:  Javier Rosa; Leandro Ferreyra Garrot; David Alejandro Navarta; Carla Saucedo; Marina Scolnik; Zaida Bedran; Maria Victoria Garcia; Mirtha Sabelli; Luis Jose Catoggio; Enrique Roberto Soriano
Journal:  J Clin Rheumatol       Date:  2013-09       Impact factor: 3.517

9.  Proliferative vascular retinopathy in polymyositis and dermatomyositis with scleroderma (overlap syndrome).

Authors:  Pradeep Venkatesh; Vivek M Bhaskar; Ravi Keshavamurthy; Satpal Garg
Journal:  Ocul Immunol Inflamm       Date:  2007 Jan-Feb       Impact factor: 3.070

10.  2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.

Authors:  Ingrid E Lundberg; Anna Tjärnlund; Matteo Bottai; Victoria P Werth; Clarissa Pilkington; Marianne de Visser; Lars Alfredsson; Anthony A Amato; Richard J Barohn; Matthew H Liang; Jasvinder A Singh; Rohit Aggarwal; Snjolaug Arnardottir; Hector Chinoy; Robert G Cooper; Katalin Dankó; Mazen M Dimachkie; Brian M Feldman; Ignacio Garcia-De La Torre; Patrick Gordon; Taichi Hayashi; James D Katz; Hitoshi Kohsaka; Peter A Lachenbruch; Bianca A Lang; Yuhui Li; Chester V Oddis; Marzena Olesinska; Ann M Reed; Lidia Rutkowska-Sak; Helga Sanner; Albert Selva-O'Callaghan; Yeong-Wook Song; Jiri Vencovsky; Steven R Ytterberg; Frederick W Miller; Lisa G Rider
Journal:  Ann Rheum Dis       Date:  2017-10-27       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.